Medical Research

Endometrial Cancer Risk Models: Insights and Clinical Limits
Clinical & Pharma Endometrial Cancer Risk Models: Insights and Clinical Limits

Endometrial cancer (EC), recognized as the most prevalent gynecologic malignancy in high-income nations, continues to pose a significant public health challenge with its incidence on a steady rise, largely fueled by escalating obesity rates and other modifiable lifestyle factors. The stakes for

Microrobot Revolutionizes Stroke Treatment with Precision
Clinical & Pharma Microrobot Revolutionizes Stroke Treatment with Precision

Imagine a world where a tiny robot, smaller than a grain of sand, can navigate the intricate maze of blood vessels in the human brain to deliver life-saving medication exactly where it’s needed, avoiding the dangerous side effects of traditional treatments. This isn’t science fiction but a

Eli Lilly and NVIDIA Build AI Supercomputer for Drug Discovery
Clinical & Pharma Eli Lilly and NVIDIA Build AI Supercomputer for Drug Discovery

Imagine a world where life-saving medicines are developed at an unprecedented pace, cutting through years of trial and error to deliver treatments to patients in record time, thanks to a groundbreaking partnership between a leading pharmaceutical company and a technology powerhouse. Their

Does Discontinuing LTOT Affect Hospitalization and Mortality?
Clinical & Pharma Does Discontinuing LTOT Affect Hospitalization and Mortality?

In the realm of respiratory care, long-term oxygen therapy (LTOT) stands as a critical intervention for patients grappling with severe hypoxemia, particularly those diagnosed with chronic obstructive pulmonary disease (COPD). This treatment, aimed at boosting survival by correcting dangerously low

Novel β-Lactamase Inhibitors Combat Klebsiella Resistance
Clinical & Pharma Novel β-Lactamase Inhibitors Combat Klebsiella Resistance

In a world increasingly threatened by antibiotic resistance, the emergence of Klebsiella pneumoniae as a major health hazard has sounded alarms across medical communities globally, highlighting the urgent need for innovative solutions. This bacterial pathogen, notorious for causing severe

Can Ultra-Processed Foods Increase Early Cancer Risk in Women?
Clinical & Pharma Can Ultra-Processed Foods Increase Early Cancer Risk in Women?

In a startling shift that has caught the attention of health experts worldwide, colorectal cancer, long regarded as a condition primarily affecting older adults, is now increasingly diagnosed in individuals under the age of 50, particularly in high-income nations like the United States. This

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later